Market data not licensed for redistribution.
Yungjin Pharm
003520 · KOSPI · Pharmaceuticals Manufacturing
Close
Source: Financial Services Commission stock price data (data.go.kr), updated once a day.
Daily price, 1 year
Key statistics
Market cap (KRW bn)–
PER–
PBR–
ROE %-7.3
Debt ratio % (liabilities / equity)164
Revenue TTM (KRW bn)253.0
Op. profit TTM (KRW bn)-4.3
Dividend yield %–
Basis: market cap at …; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (separate). PER is not shown when TTM net income is negative.
Upcoming risk events
Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.
| 2026-11-28 | Convertible bonds (CB): conversion / exercise period starts ↗ 6.87% of shares · price ₩1,999 · size ₩25.1bn | Medium |
Annual results (KRW bn)
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 196.1 | 218.4 | 234.9 | 252.0 | 254.3 |
| Operating profit | -13.9 | -7.4 | 3.1 | 8.7 | 3.4 |
| Net income | -11.6 | -22.0 | -3.9 | 1.2 | -0.2 |
Quarterly results (KRW bn, 3 months)
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | |
|---|---|---|---|---|---|---|
| Revenue | 64.1 | 62.5 | 60.9 | 66.8 | 63.8 | 61.6 |
| Operating profit | 2.6 | 1.9 | 0.0 | -1.1 | -1.8 | -1.5 |
| Net income | 1.0 | 0.3 | -1.2 | -0.4 | -2.3 | -2.4 |
Largest shareholder
As of the 2025 annual report: (주)케이티앤지 and related parties hold 52.45% of common shares.
Recent disclosures
| Date | Filing | Summary | |
|---|---|---|---|
| 2026-10-08 | Single sales/supply contract [기재정정]단일판매ㆍ공급계약체결 | DART original | |
| 2026-09-01 | Litigation 소송등의제기ㆍ신청(일정금액이상의청구) | DART original | |
| 2026-08-28 | Governance / misc. (routine) 대규모기업집단현황공시[분기별공시(개별회사용)] | DART original | |
| 2026-08-14 | Periodic report (annual/half/quarterly) 반기보고서 (2026.06) | DART original | |
| 2026-08-13 | Other 지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항 | DART original | |
| 2026-08-12 | Single sales/supply contract [기재정정]단일판매ㆍ공급계약체결 | DART original | |
| 2026-07-31 | Preliminary earnings 영업(잠정)실적(공정공시) | DART original | |
| 2026-07-24 | New facility investment [기재정정]신규시설투자등 | DART original | |
| 2026-06-01 | Governance / misc. (routine) 대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)] | DART original | |
| 2026-05-28 | Governance / misc. (routine) 기업지배구조보고서공시 | DART original | |
| 2026-05-15 | Periodic report (annual/half/quarterly) 분기보고서 (2026.03) | DART original | |
| 2026-05-06 | Preliminary earnings 영업(잠정)실적(공정공시) | DART original |
Past material filings and price reaction (market-adjusted)
| Date | Filing type | On the news (vs. market) | Next day (vs. market) | 20 days (vs. market) |
|---|---|---|---|---|
| 2026-09-01 | Litigation | +2.4% | -0.5% | -12.5% |
| 2026-07-31 | Preliminary earnings | +3.6% | +1.2% | -9.7% |
| 2026-05-06 | Preliminary earnings | -2.0% | -0.8% | -34.8% |
| 2026-01-19 | Litigation | +0.1% | +1.2% | -14.0% |
| 2026-01-16 | Revenue/profit change >=30% (15% large caps) | +0.2% | -2.7% | -16.3% |
| 2025-11-20 | Convertible bond issuance | +1.2% | +1.3% | -2.5% |
| 2025-11-05 | Preliminary earnings | -2.2% | +0.9% | -1.1% |
| 2025-08-01 | Preliminary earnings | +3.0% | -0.9% | -6.9% |
| 2025-05-07 | Preliminary earnings | -2.0% | +0.3% | +0.5% |
| 2025-01-17 | Revenue/profit change >=30% (15% large caps) | +0.3% | -0.7% | -5.7% |
For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view
Market data not licensed for redistribution.
© Crypvu · Crypto market view